Comparison of ATP-Binding Cassette Transporter Interactions with the Tyrosine Kinase Inhibitors Imatinib, Nilotinib, and DasatinibMarius Dohse, Susan E. Bates, Suresh V. Ambudkar et al.|Drug Metabolism and Disposition|2010Cited by 218
Imatinib mesylate and nilotinib (AMN107) exhibit high-affinity interaction with ABCG2 on primitive hematopoietic stem cellsCornelia Brendel, Andreas Neubauer, Christian Scharenberg et al.|Leukemia|2007Cited by 200
The Novel BCR-ABL and FLT3 Inhibitor Ponatinib Is a Potent Inhibitor of the MDR-Associated ATP-Binding Cassette Transporter ABCG2Rupashree Sen, Maria R. Baer, Karthika Natarajan et al.|Molecular Cancer Therapeutics|2012Cited by 91
The Pim kinase inhibitor SGI-1776 decreases cell surface expression of P-glycoprotein (ABCB1) and breast cancer resistance protein (ABCG2) and drug transport by Pim-1-dependent and -independent mechanismsKarthika Natarajan, Maria R. Baer, Jasjeet Bhullar et al.|Biochemical Pharmacology|2012Cited by 91
Differential effects of the immunosuppressive agents cyclosporin A, tacrolimus and sirolimus on drug transport by multidrug resistance proteinsAttaphol Pawarode, Maria R. Baer, Suneet Shukla et al.|Cancer Chemotherapy and Pharmacology|2006Cited by 76